Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Providence Medical Technology, Inc., a pioneer in less invasive solutions for spine surgery, today announced enrollment of the first patients in its prospective, randomized controlled trial (RCT) ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Subjects are randomised to receive posterior fusion using either the CORUS-LX system or the standard posterior fusion method.

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-controlled ...